BSc (Hons) Biomedical Sciences (1999–2002)

MSc Molecular Biology (2002–2003)

Northumbria University

Newcastle upon Tyne, United Kingdom

In 1999, Sotiris Georgantopoulos relocated from Greece to the United Kingdom to study at the Department of Applied Sciences, Northumbria University.

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

After obtaining his undergraduate and postgraduate degrees, Sotiris gained industry experience via employment in a major multinational consumer goods corporation. This role exposed Sotiris to the modus operandi of large organizations and laid the foundation for his future entry into the pharmaceutical industry.

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

In 2004, Sotiris was awarded a scholarship by the Faculty of Medical Sciences, Newcastle University , to conduct doctoral studies on the molecular mechanisms underlying the development of drug resistance in childhood leukaemia.

THESIS: Transcriptional regulation of the asparagine synthetase gene in childhood acute lymphoblastic leukaemia

In 2007, Sotiris was fortunate to present his research at the centennial meeting of the American Association for Cancer Research in Los Angeles, California, USA.

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

After obtaining his undergraduate and postgraduate degrees, Sotiris gained industry experience via employment in a major multinational consumer goods corporation. This role exposed Sotiris to the modus operandi of large organizations and laid the foundation for his future entry into the pharmaceutical industry.

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

In 2004, Sotiris was awarded a scholarship by the Faculty of Medical Sciences, Newcastle University , to conduct doctoral studies on the molecular mechanisms underlying the development of drug resistance in childhood leukaemia.

THESIS: Transcriptional regulation of the asparagine synthetase gene in childhood acute lymphoblastic leukaemia

In 2007, Sotiris was fortunate to present his research at the centennial meeting of the American Association for Cancer Research in Los Angeles, California, USA.

Research Fellow (2008–2009)

National University of Singapore, Singapore

Following the completion of his PhD, Sotiris was awarded a fellowship at the Department of Biochemistry, Yong Loo Lin School of Medicine, to investigate the role of reactive oxygen species in cancer.
This position allowed Sotiris to further improve his research skills in one of the top universities worldwide.

Medical Writer (2010–2011)
Self-employed
Athens, Greece

While planning a transition from academia to industry, Sotiris focused on enhancing and developing the necessary competencies that would assist him in securing a position as a Medical Writer.

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

In 2011, Sotiris was offered a Medical Writer position at MIMS Ltd.
(formerly UBM Medica) in Hong Kong – a leading provider of medical communications services in the Asia–Pacific region.
This experience introduced Sotiris to the full spectrum of medical communications services, ranging from the production of publications and advisory board development to event management and patient education.
During this period, Sotiris acquired extensive knowledge in several therapeutic areas and collaborated closely with global key opinion leaders, faculty, and medical/scientific societies.

Medical Writer (2010–2011)
Self-employed
Athens, Greece

While planning a transition from academia to industry, Sotiris focused on enhancing and developing the necessary competencies that would assist him in securing a position as a Medical Writer.

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

In 2011, Sotiris was offered a Medical Writer position at MIMS Ltd.
(formerly UBM Medica) in Hong Kong – a leading provider of medical communications services in the Asia–Pacific region.
This experience introduced Sotiris to the full spectrum of medical communications services, ranging from the production of publications and advisory board development to event management and patient education.
During this period, Sotiris acquired extensive knowledge in several therapeutic areas and collaborated closely with global key opinion leaders, faculty, and medical/scientific societies.

Medical Writer (2013–2016)
Galderma R&D SNC
Sophia Antipolis, France

Sotiris joined Galderma in 2013.
Focusing exclusively on dermatological research & development in this role, he was responsible for the planning and execution of global publication and congress communication plans.
This experience provided invaluable insight into the standards and practices in the pharmaceutical industry.

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Having established a solid base in medical writing, Sotiris founded SG Medical Writing BV in 2016.

As an independent Medical Writing/Communications Consultant, he provided an array of services to the pharmaceutical/medical device, academic, and healthcare advertising sectors, thereby substantially expanding his expertise.

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Having established a solid base in medical writing, Sotiris founded SG Medical Writing BV in 2016.

As an independent Medical Writing/Communications Consultant, he provided an array of services to the pharmaceutical/medical device, academic, and healthcare advertising sectors, thereby substantially expanding his expertise.

Artificial Intelligence in Health Care (2020)
MIT Sloan School of Management
Massachusetts Institute of Technology
Cambridge, MA, USA

In 2020, Sotiris completed an online course on the impact of artificial intelligence in health care.
This program offered a grounded understanding of the potential of artificial intelligence to transform health care by providing an overview of the technology, as well as its applications, limitations, and opportunities.

Founder (2023–present)
Epimyth MedCom
Athens, Greece

After more than two decades abroad, Sotiris returned to Greece where he founded Epimyth MedCom.
Through this endeavour, he continues to provide expert medical writing services to clients worldwide based on the scientifically sound and ethical dissemination of clinical/scientific data.

Founder (2023–present)
Epimyth MedCom
Athens, Greece

After more than two decades abroad, Sotiris returned to Greece where he founded Epimyth MedCom.
Through this endeavour, he continues to provide expert medical writing services to clients worldwide based on the scientifically sound and ethical dissemination of clinical/scientific data.

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

Medical Writer (2010–2011)
Self-employed
Athens, Greece

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

Medical Writer (2010–2011)
Self-employed
Athens, Greece

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

Medical Writer (2013–2016)
Galderma R&D SNC
Sophia Antipolis, France

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Artificial Intelligence in Health Care (2020)
MIT Sloan School of Management
Massachusetts Institute of Technology
Cambridge, MA, USA

Founder (2023–present)
Epimyth MedCom
Athens, Greece

Founder (2023–present)
Epimyth MedCom
Athens, Greece

Congratulations

Failed to complete

Research Assistant (2003–2004) Procter & Gamble Co. Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009) Northern Institute for Cancer Research Newcastle University Newcastle upon Tyne, United Kingdom

Research Assistant (2003–2004) Procter & Gamble Co. Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009) Northern Institute for Cancer Research Newcastle University Newcastle upon Tyne, United Kingdom

Medical Writer (2010–2011)Self-employed Athens, Greece

Medical Writer (2011–2013) MIMS Ltd. Hong Kong S.A.R.

Medical Writer (2010–2011)Self-employed Athens, Greece

Medical Writer (2011–2013) MIMS Ltd. Hong Kong S.A.R.

Medical Writer (2013–2016) Galderma R&D SNC Sophia Antipolis, France

Founder (2016–2023)SG Medical Writing B.V. Amsterdam, The Netherlands

Founder (2016–2023)SG Medical Writing B.V. Amsterdam, The Netherlands

Artificial Intelligence in Health Care (2020)MIT Sloan School of Management Massachusetts Institute of TechnologyCambridge, MA, USA

Founder (2023–present)Epimyth MedComAthens, Greece

Founder (2023–present)Epimyth MedComAthens, Greece

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

Research Assistant (2003–2004)
Procter & Gamble Co.
Newcastle upon Tyne, United Kingdom

PhD Molecular Pharmacology (2004–2009)
Northern Institute for Cancer Research Newcastle University
Newcastle upon Tyne, United Kingdom

Medical Writer (2010–2011)
Self-employed
Athens, Greece

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

Medical Writer (2010–2011)
Self-employed
Athens, Greece

Medical Writer (2011–2013)
MIMS Ltd.
Hong Kong S.A.R.

Medical Writer (2013–2016)
Galderma R&D SNC
Sophia Antipolis, France

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Founder (2016–2023)
SG Medical Writing B.V.
Amsterdam, The Netherlands

Artificial Intelligence in Health Care (2020)
MIT Sloan School of Management
Massachusetts Institute of Technology
Cambridge, MA, USA

Founder (2023–present)
Epimyth MedCom
Athens, Greece

Founder (2023–present)
Epimyth MedCom
Athens, Greece